CN106421641A - Traditional Chinese medicine composition and preparation for treating anorectal diseases - Google Patents

Traditional Chinese medicine composition and preparation for treating anorectal diseases Download PDF

Info

Publication number
CN106421641A
CN106421641A CN201610898051.XA CN201610898051A CN106421641A CN 106421641 A CN106421641 A CN 106421641A CN 201610898051 A CN201610898051 A CN 201610898051A CN 106421641 A CN106421641 A CN 106421641A
Authority
CN
China
Prior art keywords
parts
chinese medicine
preparation
medicine composition
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610898051.XA
Other languages
Chinese (zh)
Inventor
于菲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610898051.XA priority Critical patent/CN106421641A/en
Publication of CN106421641A publication Critical patent/CN106421641A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538Schizonepeta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • A61K36/575Magnolia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718Coptis (goldthread)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition and preparation for treating anorectal diseases. The traditional Chinese medicine composition is prepared from, by weight, 5-10 parts of rhizoma coptidis, 5-10 parts of amur cork tree bark, 5-10 parts of radix et rhizoma rhei, 3-8 parts of radix angelicae sinensis, 3-8 parts of rhizoma curcumae longae, 5-10 parts of radix angelicae, 3-8 parts of magnolia obavata herbs, 5-10 parts of pericarpium citri reticulatae, 5-10 parts of rhizoma atractylodis, 10-20 parts of herbal schizonepetae, 18-25 parts of flos lonicerae, 2-5 parts of myrrh, 12-18 parts of licorice roots and 11-13 parts of cortex dictamni. The traditional Chinese medicine composition and preparation have the effects of removing toxicity for detumescence, breaking stagnation for hemostasis, achieving astringing for analgesia, promoting wound healing and improving crissum blood circulation and have a particularly outstanding treatment effect on anus galls, bleeding, pruritus, ulceration and other symptoms; the illness state of a rectal cancer patient is relieved to a large extent after the rectal cancer patient uses the traditional Chinese medicine composition and preparation; the drug can also be used during pregnancy and lactation and is free of side effects on the human body, and no adverse reaction is caused after the drug is taken.

Description

The Chinese medicine composition for the treatment of anal and intestinal disease and preparation
Technical field
The present invention relates to field of medicaments, more particularly to a kind of Chinese medicine composition for treating anal and intestinal disease and preparation.
Background technology
Anal and intestinal disease is the distinctive commonly encountered diseases of the mankind, frequently-occurring disease.Common anal and intestinal disease have hemorrhoid, anal fistula, anal abscess, Thrombosis, anal fissure, anal ulcer etc..Anal and intestinal disease not only brings inconvenience in life, and sensual pain to patient, controls long The adverse consequencess such as anemia, skin eczema, rectum deterioration are not more also resulted in.
The Therapeutic Method of anal and intestinal disease has the method effects such as multiple, traditional operations, set bundle, laser, freezing all undesirable, Some pains are big, the course of disease is long, and had does not thoroughly easily recur, and some indications are difficult to grasp or complication is more.
With respect to above-mentioned Therapeutic Method, application is more gentle.Sold liniment on existing market, such as Ma Yinglong hemorrhoid Skin ulcer cream, bell toad enzyme, hemorrhoid gel, YUNNAN BAIYAO ZHICHUANG GAO etc., its composition has:Bell toad enzyme, Borneolum Syntheticum, Moschus, Radix Sophorae Flavescentiss, Fructus Cnidii, Calculus Boviss, Margarita, Calamina (forging), Borax, Herba Menthae etc..These medicine one side therapeutic effect have much room for improvement, on the other hand, anemia of pregnant woman And breast-feeding female patient is unusable.
Content of the invention
In view of this, the present invention provides a kind of Chinese medicine composition for treating anal and intestinal disease and preparation.
In order to realize foregoing invention purpose, the present invention provides technical scheme below:
The present invention provides a kind of Chinese medicine composition for treating anal and intestinal disease, and which is made up of the Chinese crude drug of following part by weight:
5~10 parts of Rhizoma Coptidis, 5~10 parts of Cortex Phellodendri, 5~10 parts of Radix Et Rhizoma Rhei, 3~8 parts of Radix Angelicae Sinensis, 3~8 parts of Rhizoma Curcumae Longae, the Radix Angelicae Dahuricae 5~10 Part, 3~8 parts of Cortex Magnoliae Officinalis, 5~10 parts of Pericarpium Citri Reticulatae, 5~10 parts of Rhizoma Atractylodis, 10~20 parts of Herba Schizonepetae, 18~25 parts of Flos Lonicerae, 2~5 parts of Myrrha, sweet 12~18 parts of grass, 11~13 parts of Cortex Dictamni.
Further, which is made up of the Chinese crude drug of following part by weight:
5~10 parts of Rhizoma Coptidis, 5~10 parts of Cortex Phellodendri, 5~10 parts of Radix Et Rhizoma Rhei, 3~8 parts of Radix Angelicae Sinensis, 3~8 parts of Rhizoma Curcumae Longae, the Radix Angelicae Dahuricae 5~10 Part, 3~8 parts of Cortex Magnoliae Officinalis, 5~10 parts of Pericarpium Citri Reticulatae, 5~10 parts of Rhizoma Atractylodis, 10~20 parts of Herba Schizonepetae, 18~25 parts of Flos Lonicerae, 2~5 parts of Myrrha, sweet 12~18 parts of grass, 12 parts of Cortex Dictamni.
Further, the Myrrha is Myrrha (processed).
The present invention also provides a kind of preparation of the Chinese medicine composition containing described in above-mentioned any one, and said preparation is by Chinese medicine composition The carrier or excipient composition of thing and pharmaceutical acceptable.
Further, the preparation is exterior-applied formulation.
Further, the exterior-applied formulation is unguentum, suppository, solution, liniment or spray.
Further, the exterior-applied formulation is that ointment, the ointment includes:Chinese medicine composition described in above-mentioned any one Thing, and substrate.
Further, the substrate is greasing base.
The present invention also provides a kind of preparation method of above-mentioned preparation, including:
The powder of the Chinese medicine composition described in above-mentioned any one is provided, the powder is mixed all with greasing base Even.
The present invention also provides the Chinese medicine composition described in a kind of above-mentioned any one or the preparation described in above-mentioned any one Application in treatment anal and intestinal disease medicine is prepared.
The present invention provides a kind of Chinese medicine composition and preparation, and the Chinese medicine composition and preparation have removing toxic substances and promoting subsidence of swelling, break The stasis of blood is stopped blooding, and restrains pain relieving, promotes wound healing, the effect of improve crissum blood circulation.To swelling and pain of anus, bleeding, prurituss, burst and itch Especially prominent etc. disease curative effect;In addition to diseases such as anal abscess, anal fistula, hemorrhoid, thrombosis, anal fissure anal eczema, anal ulcers With preferable curative effect.The patient of rectal cancer using after also have significantly disease amelioration.And, the age of sucking in medicine pregnancy period Can also use, body is had no side effect, react without any discomfort after medicine.
Specific embodiment
The invention discloses a kind of Chinese medicine composition for treating anal and intestinal disease and preparation, those skilled in the art can use for reference Present disclosure, is suitably modified technological parameter realization.Specifically, all similar replacements and change are to this area skill For art personnel it is it will be apparent that they are considered as including in the present invention.The method of the present invention and application have passed through relatively Good embodiment is described, and related personnel substantially can be to as herein described in without departing from present invention, spirit and scope Methods and applications are modified or suitably change and combine, and realize and apply the technology of the present invention.
A kind of Chinese medicine composition for treating anal and intestinal disease is embodiments provided, which is by the Chinese medicine of following part by weight Material constitutes:
5~10 parts of Rhizoma Coptidis, 5~10 parts of Cortex Phellodendri, 5~10 parts of Radix Et Rhizoma Rhei, 3~8 parts of Radix Angelicae Sinensis, 3~8 parts of Rhizoma Curcumae Longae, the Radix Angelicae Dahuricae 5~10 Part, 3~8 parts of Cortex Magnoliae Officinalis, 5~10 parts of Pericarpium Citri Reticulatae, 5~10 parts of Rhizoma Atractylodis, 10~20 parts of Herba Schizonepetae, 18~25 parts of Flos Lonicerae, 2~5 parts of Myrrha, sweet 12~18 parts of grass, 11~13 parts of Cortex Dictamni.
In above-mentioned Chinese medicine composition, component cooperative effect is as follows:
Rhizoma Coptidis, Cortex Phellodendri and the Radix Angelicae Dahuricae:Eliminating inflammation and expelling toxin, effect of heat clearing away are played to anus.
Radix Et Rhizoma Rhei, Radix Angelicae Sinensis, Rhizoma Curcumae Longae, Myrrha and Pericarpium Citri Reticulatae:Pain relieving, blood circulation promoting and blood stasis dispelling, the work(of loosening bowel to relieve constipation are played to anus Effect.The anal and intestinal disease that defecation does not freely cause obtains the effective treatment.
Cortex Magnoliae Officinalis:Pruritus ani and parasite, pinworm effectively suppresses.
Herba Schizonepetae, Flos Lonicerae, Cortex Dictamni, Rhizoma Atractylodis and Radix Glycyrrhizae:For anal eczema, anal ulcer, anus humidity is played well Therapeutic effect.
Preferably, above-mentioned Chinese medicine composition is made up of the Chinese crude drug of following part by weight:
5~10 parts of Rhizoma Coptidis, 5~10 parts of Cortex Phellodendri, 5~10 parts of Radix Et Rhizoma Rhei, 3~8 parts of Radix Angelicae Sinensis, 3~8 parts of Rhizoma Curcumae Longae, the Radix Angelicae Dahuricae 5~10 Part, 3~8 parts of Cortex Magnoliae Officinalis, 5~10 parts of Pericarpium Citri Reticulatae, 5~10 parts of Rhizoma Atractylodis, 10~20 parts of Herba Schizonepetae, 18~25 parts of Flos Lonicerae, 2~5 parts of Myrrha, sweet 12~18 parts of grass, 12 parts of Cortex Dictamni.
It is furthermore preferred that 8~9 parts of Rhizoma Coptidis, 7~9 parts of Cortex Phellodendri, 6~8 parts of Radix Et Rhizoma Rhei, 5~7 parts of Radix Angelicae Sinensis, 4~7 parts of Rhizoma Curcumae Longae, in vain 6~8 parts of the root of Dahurian angelica, 4~6 parts of Cortex Magnoliae Officinalis, 6~9 parts of Pericarpium Citri Reticulatae, 6~8 parts of Rhizoma Atractylodis, 12~17 parts of Herba Schizonepetae, 20~23 parts of Flos Lonicerae, Myrrha 3~4 Part, 15~17 parts of Radix Glycyrrhizae, 12 parts of Cortex Dictamni.
Most preferably, 8 parts of Rhizoma Coptidis, 8 parts of Cortex Phellodendri, 7 parts of Radix Et Rhizoma Rhei, 6 parts of Radix Angelicae Sinensis, 5 parts of Rhizoma Curcumae Longae, 7 parts of the Radix Angelicae Dahuricae, 5 parts of Cortex Magnoliae Officinalis, old 7 parts of skin, 7 parts of Rhizoma Atractylodis, 15 parts of Herba Schizonepetae, 21 parts of Flos Lonicerae, 4 parts of Myrrha, 1 part of Radix Glycyrrhizae, 12 parts of Cortex Dictamni.
Preferably, above-mentioned Myrrha is Myrrha (processed).
Accordingly, another embodiment of the present invention also provides a kind of preparation containing above-mentioned Chinese medicine composition, and said preparation is by upper State carrier or the excipient composition of Chinese medicine composition and pharmaceutical acceptable.
Said preparation is preferably exterior-applied formulation.Further, the exterior-applied formulation is unguentum, suppository, solution, liniment or spray Agent.
Above-mentioned exterior-applied formulation is preferably ointment, and the ointment includes:Above-mentioned Chinese medicine composition, and substrate.Further, Substrate is preferably greasing base, more preferably vaseline.
The preparation method of said preparation, including:
The powder of above-mentioned Chinese medicine composition is provided, the powder is mixed homogeneously with greasing base.
Above-mentioned Traditional Chinese drug mixture powder is preferably 100 mesh~300 mesh;
Greasing base is preferably vaseline, and vaseline is preferably (2~5) with the weight ratio of Chinese medicine composition powder:1.
Another preferred embodiment of the present invention also provides a kind of above-mentioned Chinese medicine composition or above-mentioned preparation and is preparing treatment anorectal Application in disease medicament.
The above-mentioned Chinese medicine composition that the present invention is provided and preparation have removing toxic substances and promoting subsidence of swelling, removing blood stasis with potent drugs hemostasis, restrain pain relieving, promote Wound healing, the effect of improve crissum blood circulation.To swelling and pain of anus, bleeding, prurituss, the disease curative effect such as itch of bursting is especially prominent; In addition to diseases such as anal abscess, anal fistula, hemorrhoid, thrombosis, anal fissure anal eczema, anal ulcers, there is preferable curative effect.Rectum The patient of cancer using after also have significantly disease amelioration.And, the age of sucking in medicine pregnancy period can also use, no secondary to body Effect, reacts without any discomfort after medicine.
With reference to embodiment, above-mentioned Chinese medicine composition and the preparation of present invention offer is expanded on further.
Embodiment 1
Traditional Chinese medicine composition formula:
5 parts of Rhizoma Coptidis, 5 parts of Cortex Phellodendri, 5 parts of Radix Et Rhizoma Rhei, 3 parts of Radix Angelicae Sinensis, 3 parts of Rhizoma Curcumae Longae, 5 parts of the Radix Angelicae Dahuricae, 3 parts of Cortex Magnoliae Officinalis, 5 parts of Pericarpium Citri Reticulatae, grey 5 parts of art, 10 parts of Herba Schizonepetae, 18 parts of Flos Lonicerae, 2 parts of Myrrha, 12 parts of Radix Glycyrrhizae, 11 parts of Cortex Dictamni.
Ointment preparation technology:
Above-mentioned Chinese medicine composition breaks into the powder of 100 mesh~200 mesh, and the powder is mixed all with the vaseline of 5 weight portions Even.
Embodiment 2
Traditional Chinese medicine composition formula:
10 parts of Rhizoma Coptidis, 10 parts of Cortex Phellodendri, 10 parts of Radix Et Rhizoma Rhei, 8 parts of Radix Angelicae Sinensis, 8 parts of Rhizoma Curcumae Longae, 10 parts of the Radix Angelicae Dahuricae, 8 parts of Cortex Magnoliae Officinalis, Pericarpium Citri Reticulatae 10 Part, 10 parts of Rhizoma Atractylodis, 20 parts of Herba Schizonepetae, 25 parts of Flos Lonicerae, 5 parts of Myrrha, 18 parts of Radix Glycyrrhizae, 13 parts of Cortex Dictamni.
Ointment preparation technology:
Above-mentioned Chinese medicine composition breaks into the powder of 200 mesh~300 mesh, and the powder is mixed all with the vaseline of 2 weight portions Even.
Embodiment 3
Traditional Chinese medicine composition formula:
8 parts of Rhizoma Coptidis, 8 parts of Cortex Phellodendri, 7 parts of Radix Et Rhizoma Rhei, 6 parts of Radix Angelicae Sinensis, 5 parts of Rhizoma Curcumae Longae, 7 parts of the Radix Angelicae Dahuricae, 5 parts of Cortex Magnoliae Officinalis, 7 parts of Pericarpium Citri Reticulatae, grey 7 parts of art, 15 parts of Herba Schizonepetae, 21 parts of Flos Lonicerae, 4 parts of Myrrha, 1 part of Radix Glycyrrhizae, 12 parts of Cortex Dictamni.
Ointment preparation technology:
Above-mentioned Chinese medicine composition breaks into the powder of 200 mesh~300 mesh, and the powder is mixed with the vaseline of 3.5 weight portions Uniformly.
【Anal abscess sufferer clinical observation】
40 anal abscess patients are randomly selected, is divided into two groups of A, B, and 20 pregnant patient are designated as tri- groups of C, the age is equal At 18~65 years old, per the preparation that group is provided using above-described embodiment 1 to 3 respectively, daily affected part medication 2 times, each medication 20g, Record curative effect, is as a result listed in table 1.
1 anal abscess sufferer clinical observation result of table
【Anal fistula sufferer clinical observation】
40 anal fistula patients are randomly selected, is divided into two groups of A, B, and 20 pregnant patient are designated as tri- groups of C, the age is all 18 ~65 years old, per the preparation that group is provided using above-described embodiment 1 to 3 respectively, the daily medication in affected part 3 times, 18-20 gram of each medication, Record curative effect, is as a result listed in table 2.
2 anal fistula sufferer clinical observation result of table
【Hemorrhoid sufferer clinical observation】
40 hemorrhoid patients are randomly selected, is divided into two groups of A, B, and 20 pregnant patient are designated as tri- groups of C, the age is all 18 ~65 years old, per the preparation that group is provided using above-described embodiment 1 to 3 respectively, the daily medication in affected part 2 times, 18-20 gram of each medication, Record curative effect, is as a result listed in table 3.
3 hemorrhoid sufferer clinical observation result of table
【Anal fissure sufferer clinical observation】
Randomly select 60 anal fissure patients, be divided into two groups of A, B, C, the age all at 18~65 years old, per group respectively using above-mentioned The preparation that embodiment 1 to 3 is provided, the daily medication in affected part 2 times, 18-20 gram of each medication, curative effect is recorded, is as a result listed in table 4.
4 anal fissure sufferer clinical observation result of table
【Thrombosis sufferer clinical observation】
Randomly select 60 thrombosis patients, be divided into two groups of A, B, C, the age all at 18~65 years old, per group respectively using above-mentioned The preparation that embodiment 1 to 3 is provided, the daily medication in affected part 2 times, 18-20 gram of each medication, curative effect is recorded, is as a result listed in table 5.
5 thrombosis sufferer clinical observation result of table
【Anal eczema, anal ulcer sufferer clinical observation】
Randomly select 60 thrombosis patients, the preparation for being provided using above-described embodiment 3, apply in affected part daily using 2 times, per 18-20 gram of secondary medication can reach 80% healing using 3-7 days diseases.
【Rectal cancer late period sufferer clinical observation】
3 rectal cancer late period sufferers of selection, the preparation for being provided using embodiment 3, disease amelioration, are palliated the agonizing sufferings, prolong immediately The life of 2-6 month is grown.
As shown in the above, the Chinese medicine composition of present invention offer and preparation are to swelling and pain of anus, bleeding, prurituss, bursting The disease curative effect such as itch is especially prominent;In addition to diseases such as anal abscess, anal fistula, hemorrhoid, thrombosis, anal fissure anal eczema, anal ulcers Disease has preferable curative effect.The patient of rectal cancer using after also have significantly disease amelioration.And, the medicine pregnancy period suckling Phase can also use, and body is had no side effect, and react without any discomfort after medicine.
The above is only the preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art For member, under the premise without departing from the principles of the invention, some improvements and modifications can also be made, these improvements and modifications also should It is considered as protection scope of the present invention.

Claims (10)

1. a kind of Chinese medicine composition for treating anal and intestinal disease, it is characterised in that be made up of the Chinese crude drug of following part by weight:
5~10 parts of Rhizoma Coptidis, 5~10 parts of Cortex Phellodendri, 5~10 parts of Radix Et Rhizoma Rhei, 3~8 parts of Radix Angelicae Sinensis, 3~8 parts of Rhizoma Curcumae Longae, 5~10 parts of the Radix Angelicae Dahuricae, 3~8 parts of Cortex Magnoliae Officinalis, 5~10 parts of Pericarpium Citri Reticulatae, 5~10 parts of Rhizoma Atractylodis, 10~20 parts of Herba Schizonepetae, 18~25 parts of Flos Lonicerae, 2~5 parts of Myrrha, Radix Glycyrrhizae 12~18 parts, 11~13 parts of Cortex Dictamni.
2. Chinese medicine composition according to claim 1, it is characterised in which is made up of the Chinese crude drug of following part by weight:
5~10 parts of Rhizoma Coptidis, 5~10 parts of Cortex Phellodendri, 5~10 parts of Radix Et Rhizoma Rhei, 3~8 parts of Radix Angelicae Sinensis, 3~8 parts of Rhizoma Curcumae Longae, 5~10 parts of the Radix Angelicae Dahuricae, 3~8 parts of Cortex Magnoliae Officinalis, 5~10 parts of Pericarpium Citri Reticulatae, 5~10 parts of Rhizoma Atractylodis, 10~20 parts of Herba Schizonepetae, 18~25 parts of Flos Lonicerae, 2~5 parts of Myrrha, Radix Glycyrrhizae 12~18 parts, 12 parts of Cortex Dictamni.
3. Chinese medicine composition according to claim 1, it is characterised in that the Myrrha be.
4. the preparation containing the Chinese medicine composition described in claim 1 to 3 any one, it is characterised in that said preparation is by Chinese medicine group The carrier or excipient composition of compound and pharmaceutical acceptable.
5. preparation according to claim 4, it is characterised in that the preparation be.
6. preparation according to claim 5, it is characterised in that the exterior-applied formulation be Or spray.
7. preparation according to claim 6, it is characterised in that the exterior-applied formulation is that ointment, the ointment includes:Right Require the Chinese medicine composition described in 1 to 3 any one, and substrate.
8. preparation according to claim 7, it is characterised in that the substrate be.
9. the preparation method of the preparation described in a kind of claim 8, it is characterised in that include:
The powder of the Chinese medicine composition described in claims 1 to 3 any one is provided, the powder is mixed with greasing base Uniformly.
10. the preparation described in Chinese medicine composition described in claims 1 to 3 any one or claim 4 to 7 any one exists Prepare the application in treatment anal and intestinal disease medicine.
CN201610898051.XA 2016-10-14 2016-10-14 Traditional Chinese medicine composition and preparation for treating anorectal diseases Pending CN106421641A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610898051.XA CN106421641A (en) 2016-10-14 2016-10-14 Traditional Chinese medicine composition and preparation for treating anorectal diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610898051.XA CN106421641A (en) 2016-10-14 2016-10-14 Traditional Chinese medicine composition and preparation for treating anorectal diseases

Publications (1)

Publication Number Publication Date
CN106421641A true CN106421641A (en) 2017-02-22

Family

ID=58174768

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610898051.XA Pending CN106421641A (en) 2016-10-14 2016-10-14 Traditional Chinese medicine composition and preparation for treating anorectal diseases

Country Status (1)

Country Link
CN (1) CN106421641A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113769038A (en) * 2021-10-11 2021-12-10 于菲 Externally-applied ointment capable of being absorbed efficiently and used for treating anorectal diseases

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1249182A (en) * 1998-09-29 2000-04-05 龙会全 Lotion for treating venereal disease, gynopathy and dermatopathy and its preparing process
CN102552611A (en) * 2012-02-24 2012-07-11 北京市肛肠医院 Traditional Chinese medicine combination for treating haemorrhoids
CN103751447A (en) * 2014-02-11 2014-04-30 王雪雁 Pharmaceutical composition for treating hemorrhoid disease of pregnant and lying-in woman and preparation method thereof
CN104523912A (en) * 2014-12-09 2015-04-22 杨向东 Pharmaceutical composition treating anorectal diseases, and preparation method and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1249182A (en) * 1998-09-29 2000-04-05 龙会全 Lotion for treating venereal disease, gynopathy and dermatopathy and its preparing process
CN102552611A (en) * 2012-02-24 2012-07-11 北京市肛肠医院 Traditional Chinese medicine combination for treating haemorrhoids
CN103751447A (en) * 2014-02-11 2014-04-30 王雪雁 Pharmaceutical composition for treating hemorrhoid disease of pregnant and lying-in woman and preparation method thereof
CN104523912A (en) * 2014-12-09 2015-04-22 杨向东 Pharmaceutical composition treating anorectal diseases, and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
安阿月主编: "《肛肠疾病》", 31 October 1999 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113769038A (en) * 2021-10-11 2021-12-10 于菲 Externally-applied ointment capable of being absorbed efficiently and used for treating anorectal diseases

Similar Documents

Publication Publication Date Title
CN101167847B (en) Traditional Chinese medicinal white spirit preparation for effectively treating skin disease
EP3466447A1 (en) Topical pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof
CN102247581B (en) Medicament for treating myoma of uterus
CN103027965A (en) Traditional Chinese medicine combination for treating hemorrhoids and preparation method thereof
CN101966250B (en) Externally applied Chinese medicament for treating burn and manufacturing method thereof
CN102178811B (en) Medicament for treating skin ulcer and preparation method thereof
CN106421641A (en) Traditional Chinese medicine composition and preparation for treating anorectal diseases
CN1059595C (en) Method for preparing piles medicament
CN105056154A (en) Traditional Chinese medicine compound gel dispersible patch for curing rheumatic arthralgia
CN100556425C (en) A kind of Chinese medicine unguentum of analgetic, hemostatic repercussive and sore-arresting functions
CN101391053B (en) Traditional Chinese medicine composition for treating hemorrhoid
CN115887601B (en) A composition for treating hemorrhoid and its preparation method
CN111298053A (en) Bezoar dragon bone ointment for treating hemorrhoid
CN103181964B (en) Traditional Chinese medicine composition for treating animal body surface injuries and preparation method thereof
CN102697928B (en) Preparation method for medicine composition for treating traumatic injury
CN101869623B (en) Medicament for treating trichoepithelioma and preparation method thereof
CN107551032B (en) A Chinese medicinal composition for treating external hemorrhoid and internal hemorrhoid, and its preparation method
CN101983681A (en) Medicament for treating abnormal leucorrhea
CN104666784A (en) Acne treating capsules and preparation method thereof
CN105617273A (en) Pharmaceutic preparation for promoting wound healing and application thereof
CN104971209A (en) Externally used agent for treating tinea pedis and preparation method thereof
CN105250433A (en) External use traditional Chinese medicine ointment for treating haemorrhoids and preparing method of external use traditional Chinese medicine ointment
CN115429859A (en) Traditional Chinese medicine composition for treating skin pruritus diseases and preparation method and application thereof
CN104740140A (en) Nursing medicament for treating burns and scalds
CN110711219A (en) Granular preparation of sophora flower elm

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170222

RJ01 Rejection of invention patent application after publication